MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

Cancer Gene Therapy

Volumn 19, Issue 11, 2012, Pages 773-778

  Zang, Y S ^a   Zhong, Y F ^b   Fang, Z ^a   Li, B ^a   An, J ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY   (China)

Author keywords

Apaf 1; apoptosis; cisplatin; DNA damage; lung cancer; miR 155

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CISPLATIN; MESSENGER RNA; MICRORNA 155;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; DRUG SENSITIVITY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; LUNG ADENOCARCINOMA; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASE 9; CELL LINE, TUMOR; CISPLATIN; COMET ASSAY; DNA DAMAGE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; MICRORNAS; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84867745041     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2012.60     Document Type: Article

References (30)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Engels BM, Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 2006; 25: 6163-6169.
3. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 2006; 34: D140-D144.
4. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006; 125: 887-901.
5. Yi R, Qin Y, Macara IG, Cullen BR. Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev 2003; 17: 3011-3016.
6. Chendrimada TP, Finn KJ, Ji X, Baillat D, Gregory RI, Liebhaber SA et al. MicroRNA silencing through RISC recruitment of eIF6. Nature 2007; 447: 823-828.
7. Tam W. Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA. Gene 2001; 274: 157-167.
8. Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 2009; 1792: 497-505.
9. Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED et al. The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res 2011; 17: 1875-1882.
10. Zheng D, Haddadin S, Wang Y, Gu LQ, Perry MC, Freter CE et al. Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol 2011; 4: 575-586.
11. Babar IA, Czochor J, Steinmetz A, Weidhaas JB, Glazer PM, Slack FJ. Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells. Cancer Biol Ther 2011; 12: 908-914.
12. Giaccone G. Clinical perspectives on platinum resistance. Drugs 2000; 59(Suppl 4): 9-17discussion 37-38.
13. Okouoyo S, Herzer K, Ucur E, Mattern J, Krammer PH, Debatin KM et al. Rescue of death receptor and mitochondrial apoptosis signaling in resistant human NSCLC in vivo. Int J Cancer 2004; 108: 580-587.
14. Mueller T, Voigt W, Simon H, Fruehauf A, Bulankin A, Grothey A et al. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res 2003; 63: 513-521.
15. Riedl SJ, Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol 2007; 8: 405-413.
16. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: tiny players in a big field. Immunity 2007; 26: 133-137.
17. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B et al. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179: 5082-5089.
18. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
19. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res 2009; 69: 5776-5783.
20. Dorsett Y, McBride KM, Jankovic M, Gazumyan A, Thai TH, Robbiani DF et al. MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 2008; 28: 630-638.
21. Qin A, Zhou Y, Sheng M, Fei G, Ren T, Xu L. Effects of microRNA-155 on the growth of human lung cancer cell line 95D in vitro. Zhongguo Fei Ai Za Zhi 2011; 14: 575-580.
22. Reubold TF, Wohlgemuth S, Eschenburg S. Crystal structure of full-length Apaf-1: how the death signal is relayed in the mitochondrial pathway of apoptosis. Structure 2011; 19: 1074-1083.
23. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-11556.
24. Sancho M, Herrera AE, Gortat A, Carbajo RJ, Pineda-Lucena A, Orzáez M et al. Minocycline inhibits cell death and decreases mutant Huntingtin aggregation by targeting Apaf-1. Hum Mol Genet 2011; 20: 3545-3553.
25. Mondragón L, Galluzzi L, Mouhamad S, Orzáez M, Vicencio JM, Vitale I et al. A chemical inhibitor of Apaf-1 exerts mitochondrioprotective functions and interferes with the intra-S-phase DNA damage checkpoint. Apoptosis 2009; 14: 182-190.
26. Shawgo ME, Shelton SN, Robertson JD. Caspase-mediated Bak activation and cytochrome c release during intrinsic apoptotic cell death in Jurkat cells. J Biol Chem 2008; 283: 35532-35538.
27. Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D et al. MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 2010; 285: 17869-17879.
28. Koch M, Mollenkopf HJ, Klemm U, Meyer TF. nduction of microRNA-155 is TLR-and type IV secretion system-dependent in macrophages and inhibits DNA-damage induced apoptosis. Proc Natl Acad Sci USA 2012; 109: E1153-E1162.
29. Crawford N, Chacko AD, Savage KI, McCoy F, Redmond K, Longley DB et al. Platinum resistant cancer cells conserve sensitivity to BH3 domains and obatoclax induced mitochondrial apoptosis. Apoptosis 2011; 16: 311-320.
30. Wang G, Rong J, Zhou Z, Duo J. Novel gene P28GANK confers multidrug resistance by modulating the expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells. Mol Biol (Mosk) 2010; 44: 1010-1017.